Every intervention Outliyr has scored for kids, ranked by its BioHarmony score for this use case rather than its overall rating. The number beside each name is how well that one thing works for kids; the tier beside it is what it is worth once safety, cost and effort are counted across everything else.
28 of 91 evaluated interventions score 3.0+ out of 10 for kids · 3 comparisons
Pediatric evidence is stronger than general adult evidence because lactoferrin is a milk protein with direct relevance to infants and children. Ariff 2025 was mixed in low-birth-weight neonates, while ELFIN 2019 was…
Systematic reviews confirm feasibility and efficacy in children aged 6 and up; safe non-pharmacological option for pediatric anxiety. The new Eddie 2025 JAMA Psychiatry RCT (n=115) extending HRVB to substance use disorder…
Whole-Body Vibration is being explored for rehabilitation of motor deficits in this population, but the evidence base remains limited to small randomized trials and short-term outcomes. Reported improvements focus on lower-extremity strength…
The evidence points to a plausible use case without proving a universal response. Leung GKW et al. 2025 is the best anchor here because it reports 33 randomized trials and 2821 individuals…
Melatonin has meaningful pediatric sleep evidence in autism and ADHD contexts, but pediatric use needs stricter oversight because accidental ingestion has become common. A meta-analysis in autism found sleep-onset latency improved by…
Kodama 2009 is the cleanest verified anchor for this report. The existing rationale points to this narrower claim: Aerobic fitness in childhood predicts later cardiometabolic health, and easy cycling, sports, hiking, or…
Hellhammer et al. 2004 gives the strongest anchor. Pediatric evidence is meaningful but adjunctive. Manor 2012 tested PS-omega-3 in 200 children, Hirayama 2014 tested PS alone in a smaller trial, and Lee…
Semaglutide has adolescent obesity relevance, but this category needs stricter oversight than adult weight loss. FDA 2024 reflects the seriousness of prescription indications, even though this cited approval is adult cardiovascular risk.…
Metformin in the pediatric context requires clinician oversight because it can cause gastrointestinal upset, affect growth, and impact renal function and vitamin B12 levels. The evidence tier for pediatric Metformin is low,…
Sacks 2001 supports the strongest part of the claim. The existing rationale points to this narrower claim: Oral rehydration solution is standard for pediatric diarrheal dehydration. the cited study Cochrane abstract supports…
The protocol was designed for adults and has limited direct child-specific evidence Helgerud 2007. Adolescents can benefit from intervals when intensity is scaled, technique is coached, and sport context is appropriate. The…
The evidence points to a plausible use case without proving a universal response. Chang et al. 2023 is the best anchor here because it reports corrected ADHD PMID from audit and modest…
The strongest narrow evidence involves breath-holding-spell literature rather than adult enhancement. The strongest support comes from Cohen P. et al. 2020, but the practical rating stays bounded by study size, replication, and…
Pediatric growth-hormone deficiency is the one use case where sermorelin has genuine regulatory-grade proof. A 110-patient pivotal trial showed reliable height-velocity gains in growth-hormone-deficient children and earned the Geref FDA approval, per…
No broad pediatric supplementation evidence. Pediatric use should stay clinician-directed.
No pediatric Ca-AKG evidence. Pediatric use should be avoided outside clinician-directed metabolic or nutrition contexts.
No pediatric indication was verified. Children with amino-acid metabolism disorders can be harmed by inappropriate amino acid intake.
Lyon 2011 supports pediatric ADHD sleep use, but pediatric use should be clinician-guided and not generalized beyond that evidence.
Pediatric evidence is mixed and medical-context dependent. Sangild 2021 reviews potential pediatric gut and infection uses, while Yao 2026 cautions against recommending bovine colostrum for preterm feeding intolerance based on current RCT…
Some pediatric IBS and IBD trial data exists, mixed, and only in clinical contexts.
Pediatric disease use exists in specific specialist contexts, but healthy pediatric optimization is unsupported and inappropriate.
Adolescent athlete use exists, but pediatric evidence is limited and should be supervised.
Some pediatric immune-deficiency contexts exist historically, but thymosin alpha-1 is not a default pediatric intervention. Pediatric use requires specialist supervision.
Lopresti 2018 tested affron in youth anxiety and depressive symptoms, but pediatric evidence is too narrow for broad use without clinician guidance.
Tsai 2007 discusses ADHD and Rett syndrome potential, but it is hypothesis-level support rather than pediatric clinical validation outside Russian practice.
Pediatric medical indications exist in specialist care contexts. Autism and general pediatric neurodevelopment claims are weak and controversial. Rossignol 2009 reports short-term behavioral changes that have not held up in later reviews.…
Pediatric growth is the one place GHRP-2 has a genuine clinical outcome rather than a biomarker: in growth-hormone-deficient children, height velocity rose from 3.7 to 6.1 cm per year on daily dosing,…
FDA-approved for juvenile rheumatoid arthritis in children 2 years and older, but pediatric use requires dosing and safety oversight. CYP2C9 poor metabolizers need special caution.
Nothing matches those filters.
Monthly out-of-pocket cost at the most accessible legitimate channel, at the dose the score was given for. 8 of 28 are not priced yet; those cells are left blank rather than guessed.
| Intervention | Monthly cost | At dose | How you get it |
|---|---|---|---|
| Lactoferrin | $25–$50 | 250-300 mg apolactoferrin | Over the counter |
| HRV Biofeedback | $5 | 20 min/session at individual RF (4.5 to 6.5 bpm) | Over the counter |
| Whole-Body Vibration | $50–$100 | 30 Hz, roughly 0.3g, 10-20 min standing | Over the counter |
| Ketogenic Diet | $100 | Standard keto, 40-50 g total carbohydrate/day | Over the counter |
| Melatonin | $3–$8 | 0.5 to 3 mg | Over the counter |
| Zone 2 Cardio | Not priced yet | Over the counter | |
| Phosphatidylserine | $20–$50 | 300 mg/day total, split as 100 mg three times daily or 300 mg once daily with food | Over the counter |
| Semaglutide | $199–$349 | 0.25 mg weeks 1 to 4, 0.5 mg weeks 5 to 8, 1.0 mg weeks 9 to 12, 1.7 mg weeks 13 to 16, 2.4 mg week 17 onward | Prescription |
| Metformin | $4–$30 | 500 mg with dinner for 1 week, then 500 mg twice daily for 1 week, then increase by 500 mg/week toward 1000 mg twice daily as tolerated | Prescription |
| Electrolytes | Not priced yet | ||
| Norwegian 4×4 | Not priced yet | Over the counter | |
| Omega-3 | $20–$40 | 1-2 g/day combined EPA+DHA | Over the counter |
| Piracetam (Nootropil) | $8–$20 | 2.4-4.8 g | Grey market |
| Sermorelin (GHRH 1-29) | $129–$250 | 100 mcg | Prescription |
| Glycine | $2–$3 | 3 g oral glycine | Over the counter |
| Ca-AKG (Calcium Alpha-Ketoglutarate) | $15–$30 | 1 g/day generic Ca-AKG oral | Over the counter |
| Essential Amino Acids | Not priced yet | ||
| L-Theanine | $3–$8 | 200 mg L-theanine + 100 mg caffeine | Over the counter |
| Colostrum | $60–$80 | 20 g/day powder, split AM/PM if tolerated | Over the counter |
| Sodium Butyrate | Not priced yet | ||
| Rapamycin | $15–$50 | 3 mg | Prescription |
| Blood-Flow Restriction Training | Not priced yet | ||
| Thymosin Alpha-1 | $100–$400 | 1.6 mg subcutaneous | Prescription |
| Saffron | Not priced yet | ||
| Semax | $12–$60 | 300-600 mcg/day of 0.1% spray | Grey market |
| Hyperbaric Oxygen Therapy | $3,000–$6,000 | 2.0 ATA for 90 minutes with air breaks | In clinic |
| GHRP-2 (Pralmorelin) | $20–$40 | 100 mcg | Grey market |
| Celebrex (Celecoxib) | Not priced yet |
Head-to-head reports and category rankings that name a winner on this use case.
Melatonin, dosed low. It scores 7.5–8.0/10 against apigenin's 5.5–6.0/10 and wins the sleep rows outright. The morning hangover apigenin markets against comes from taking too much, not from…
Both score anxiety 7.5–8.0/10, so the tie-breaker is time. L-theanine works in about an hour and you take it when you need it. Ashwagandha takes eight weeks and…
Lactoferrin scores 7.0–7.5/10 against colostrum's 6.5–7.0/10, and lactoferrin is one protein inside colostrum. Buy lactoferrin when iron handling, acne or H. pylori is the target, at $25 to…
Lactoferrin, at 8.0–8.5 out of 10 for kids. Pediatric evidence is stronger than general adult evidence because lactoferrin is a milk protein with direct relevance to infants and children.
Of the top-scoring options, Glycine is the least expensive at about $2 a month, scoring 4.5–5.0 out of 10 for kids.
28 of the 91 interventions evaluated for kids score 3.0 out of 10 or better, which is the cut-off for appearing on this page.
